Travel considerations specified for 177Lu-DOTATATE radiation therapy patients

A team of researchers and patient advocates have addressed the challenges related to traveling after receiving 177Lu-DOTATATE radiation therapy in a study published in the April issue of The Journal of Nuclear Medicine. Due to the residual radiation activity of 177Lu-DOTATATE, neuroendocrine tumor patients have experienced travel delays at U.S. ports of entry. It is recommended that patients carry a […]

Continue reading »

Unique Namibian trial finds smart interventions reduce malaria transmission by 75%

A trial by scientists at the Wits Research Institute for Malaria (WRIM), in collaboration with Namibian, UK, and US researchers demonstrates how mass drug administration and vector control can help eliminate malaria. A vector refers to an organism that transmits infection, as mosquitos infected with parasites transmit malaria to people. The researchers published their findings in the prestigious journal The […]

Continue reading »

New guidance to support psychological needs of nursing staff during COVID-19 pandemic

,Researchers from the University of Southampton and University of Surrey have developed new guidance to support the psychological and mental health needs of nursing staff at the frontline of the fight against COVID-19. Published in the Journal of Clinical Nursing, researchers identify the stressors and challenges nurses face during the COVID-19 pandemic and have developed guidance offering strategies for nursing […]

Continue reading »

New understanding of asthma medicines could improve future treatment

New research has revealed new insights into common asthma aerosol treatments to aid the drug’s future improvements which could benefit hundreds of millions of global sufferers. Lung diseases such as asthma are a major global health burden, with an estimated 330 million asthma sufferers worldwide. The most effective treatments are through direct inhalation of medicine to the lungs. However, generating […]

Continue reading »

Study finds no overall survival benefit, but improved quality of life with talazoparib in BRCA-mutated breast cancer

New data from the Phase III EMBRACA trial led by researchers at The University of Texas MD Anderson Cancer Center found the PARP inhibitor talazoparib did not demonstrate a statistically significant overall survival (OS) benefit for patients with metastatic HER2-negative breast cancer and mutations in the BRCA1/2 genes. Most patients included in the study went on to receive subsequent systemic […]

Continue reading »

Big fall in COVID-19 deaths in France

Credit: CC0 Public Domain France reported a big fall in its coronavirus toll on Sunday, with 242 deaths in 24 hours, a drop of more than a third on the previous day. The epidemic has now claimed 22,856 lives in the country since the beginning of March, health officials said. The number of deaths in hospitals—152—was the lowest daily toll […]

Continue reading »

Canada’s reopening won’t depend on immunity: Trudeau

Prime Minister Justin Trudeau said Saturday that Canada’s approach to reopening its economy from the coronavirus shutdown would be “cautious” and not depend on the development of widespread immunity in the population. “I don’t think there are any of the plans that hinge on certain people or individuals being immune or having immunity to COVID-19,” he said at a daily […]

Continue reading »
1 146 147 148 149 150 212